Nearly half of US rheumatologists expect Gazyva to meaningfully reshape SLE treatment pathways, while CAR T-cell therapy is ...

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.

In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.

Systemic lupus erythematosus is associated with an increased risk for 16 cancers, including Hodgkin’s and non-Hodgkin’s lymphoma, leukemia and multiple myeloma, but a decreased risk for prostate ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Among patients with SLE-associated PAH, those with rare PAH-related gene variants have a unique vasculopathy phenotype and worse outcomes.

Patients of Asian heritage were also more likely to have end-organ manifestation, the authors found. Hispanic and Asian patients face a heightened risk of renal, hematologic, and multi-organ ...

When choosing my home for the next four years, it was Stanford’s distinct — but largely under-advertised — residential program that tipped the scale for me. Like most international Indian applicants, ...